Effects of Nitrates and Citrulline Malate on Performance in Professional Professional Soccer (NiCiFut)

November 23, 2023 updated by: Francisco Javier López Román, Universidad Católica San Antonio de Murcia

Experimental Study to Evaluate the Effects of Effects of a Sports Supplement Based on Nitrates and Citrulline Malate on Performance in Professional Soccer Players

Randomized, single-center, parallel, team-stratified, stratified experimental study to evaluate the efficacy of a high sports supplement in improving high-intensity intermittent exercise performance in professional female soccer players.

Study Overview

Detailed Description

Subjects who meet the selection criteria will be randomly assigned to each of the study groups (investigational product or placebo, depending on the group to which they have been assigned).

The product to be consumed will be Nitrates and Citrulline Malate. Participants will consume the product for 30 days. The intake should be done two hours before each training session and the same dose will be consumed.

The women's soccer players will perform a stress test with gas analysis to measure performance, as well as a Wingate test without consumption of the products. Five days later, the players will perform the Yo-Yo IR1 test in the field and will repeat the same tests performed at the beginning of the test after product consumption.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Murcia, Spain, 30107
        • Catholic University of Murcia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Present at the time of signing the informed consent at the age between 18 and 40 years.
  • Female.
  • Healthy subjects without any chronic disease.
  • Volunteers capable of understanding the clinical study, willing to give their written informed. consent and comply with the procedures and requirements of the study. and requirements of the study.

Exclusion Criteria:

  • Players who change teams during the experimental study.
  • Smoking subjects.
  • Subjects using mouthwashes during the study.
  • Subjects with a history of drug, alcohol or other substance abuse or other factors that limit their ability to cooperate during the study. factors that limit their ability to cooperate during the study.
  • Subjects whose status makes them ineligible for the study, at the discretion of the investigator discretion of the investigator.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Nitrates and Citrulline Malate
Gel elaborated from fruit puree with high polyphenol content, with the addition of nitrates and citrulline malate as study supplements. addition of nitrates and citrulline malate as study supplements.

Female soccer players should consume the experimental product for 30 days to evaluate the efficacy of a sports supplement high in nitrates combined with citrulline malate in the improvement of performance in high-intensity intermittent exercise.

high intensity

Placebo Comparator: Control product
Consumption of placebo product (Fruit puree)
Fruit puree

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Aerobic and anaerobic thresholds - VO2max
Time Frame: Change in initial maximal oxygen consumption at 30 days
Measured with a gas analyzer
Change in initial maximal oxygen consumption at 30 days
Fatigue in jumping
Time Frame: Change in initial jump fatigue at 30 days
Measured with a contact platform
Change in initial jump fatigue at 30 days
Anaerobic capacity
Time Frame: Change in baseline anaerobic capacity at 30 days
Measured with a Monark cycloergometer
Change in baseline anaerobic capacity at 30 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Microcapillary blood
Time Frame: It will be measured on two different occasions. Day one and 30 days later.
This test provides biochemical variables (ABL90FLEX) with 70 ml of capillary blood.
It will be measured on two different occasions. Day one and 30 days later.
Lactate
Time Frame: It will be measured on two different occasions. One on the first day (without intake of product ) and 30 days later, the same measurements but after having consumed the product
Lactate levels will be measured using the Lactate Pro
It will be measured on two different occasions. One on the first day (without intake of product ) and 30 days later, the same measurements but after having consumed the product
Safety variables
Time Frame: It will be measured on two different occasions. Day one and 30 days later.
It is a blood test that measures the presence of some enzymes, proteins and bilirubin in the blood, with the aim of determining if there is any alteration in the liver.
It will be measured on two different occasions. Day one and 30 days later.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 15, 2022

Primary Completion (Actual)

September 10, 2022

Study Completion (Actual)

January 20, 2023

Study Registration Dates

First Submitted

August 9, 2022

First Submitted That Met QC Criteria

August 30, 2022

First Posted (Actual)

September 2, 2022

Study Record Updates

Last Update Posted (Actual)

November 27, 2023

Last Update Submitted That Met QC Criteria

November 23, 2023

Last Verified

July 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • UCAMCFE-00027

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Supplementation

Clinical Trials on Nitrates and Citrulline Malate

Subscribe